MIG AG

About The Fund

MIG Verwaltungs AG (MIG AG) is one of the leading German VC Investors focusing on deep technology and life science sectors. They manage 15 MIG public venture funds, which are regulated by the German Federal Financial Supervisory Authority (BAFIN) and have more than 900 million Euros of committed capital contributed by over 50,000 private investors. With a diversified investment strategy, they support companies from early to later stages, offering investments ranging between 2,600,000 and 17,800,000 Euros. Their investment thesis revolves around identifying and nurturing innovative companies that are poised to set new benchmarks within their respective industries. The current active portfolio of MIG AG consists of 33 companies, with special attention paid to domains such as software (Web, Marketplace, SaaS), IT & TMT, biotechnology, hardware & manufacturing, material science, medical devices & hospital services, robotics, real estate & construction, investment management, life science, and oncology. MIG AG has achieved significant milestones that include 24 partial or complete exits, four IPOs, and the successful backing of two 'unicorn' companies. Some of MIG AG’s portfolio companies offer pioneering solutions like intelligent power suits developed by German Bionic, unique cancer-targeting immune checkpoints from iOmx, ultra-thin polyurethane balloons for medical applications by Creative Balloons, neuromorphic processors for ultra-low-power intelligence from Innatera, and silicon carbide production for power semiconductors in electric vehicles by Zadient Technology. MIG AG, with its team of experts ranging from physicists and biologists to engineers and chemists, and above all entrepreneurs, endeavors to transform visions into values by shaping the companies of tomorrow. Goals are meant to be continuously achieved, and MIG AG pursues this ideology by investing in groundbreaking companies that will define the future of technology and life sciences.